Study title: Report/protocol/study N°: Controlled clinical study of ZY 15021 Investigator: C. Pulino Report date: 5 May 1986 Design: randomized, single-blind, comparative Objective: evaluation of efficacy and safety of ZY 15021 used with antibiotics Population: subjects with laryngo-pharyngo-tonsillar disorders Evaluations: pharyngeal pain, pain in swallowing, dysphonia, oropharyngeal inflammation; side effects Total (verum; comparator): 28 (14, 14) Age (mean, range): 13-57 years
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Respiratory Tract Diseases [C08] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: BENZOXONIUM CHLORIDE/BENZOXONIUM AND LIDOCAINE | |||||
| ATC code: | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | Y | |